At the last check on Thursday, P3 Health Partners Inc.’s (NASDAQ:PIII) stock was up $0.11, moving up 5.58 percent to $2.08. The average number of shares traded per day over the past five days has been 732,087 shares. 5 times new highs have been achieved over the past 5 days, with a $0.6650 gain in that time frame. In the last twenty days, the average volume was 363,067, while in the previous 50 days, it was 384,649.
Since last month, PIII stock retreated -0.48%. Shares of the company fell to $1.3050 on 08/25/23, the lowest level in the past month. A 52-week high of $7.05 was reached on 06/06/23 after having rallying from a 52-week low of $0.70. Since the beginning of this year, PIII’s stock price has risen by 13.04% or $0.2300, and marked a new high 9 times. However, the stock has declined by -70.50% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
PIII stock investors should be aware that P3 Health Partners Inc. (PIII) stock had its last reported insider trading activity 1 day ago on Aug 30. Chicago Pacific Founders UGP I, the 10% Owner of the company, purchased of 90,000 shares for $1.83 on Aug 30. It resulted in a $164,826 investment by the insider. Chicago Pacific Founders UGP I added 90,000 shares at an average price of $1.70 on Aug 29. The insider now owns 49,215,442 shares following the transaction. On Aug 28, 10% Owner Chicago Pacific Founders UGP I bought 90,000 shares at $1.39 apiece. The transaction was valued at $125,145.
Financial Health
In the three months ended June 29, P3 Health Partners Inc.’s quick ratio stood at 0.70, while its current ratio was 0.70, showing that the company is not able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 2.30% percent. In the year ended June 29, EBITDA margin amounted to -15.12%, whereas operating margins totaled -58.60%. Based on annual data, PIII earned -$7.75 million in gross profit and brought in $1.05 billion in revenue.
In P3 Health Partners Inc.’s quarter-end financial report for June 29, it reported total debt of $108.19 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. PIII’s revenue rose 18.12% to $302.08 million during the quarter, while net income inched up to $329.09 million. While analysts expected P3 Health Partners Inc. to report -$0.13 quarterly earnings, the actual figure was -$0.09 per share, beating the consensus estimate by 30.80%. During the quarter, the company generated $0.81 million in EBITDA. The liabilities of P3 Health Partners Inc. were 1.05 billion at the end of its most recent quarter ended June 29, and its total debt was $119.98 million. The value of shareholders’ equity is $312.68 million.
Technical Picture
This quick technical analysis looks at P3 Health Partners Inc.’s (PIII) price momentum. With a historical volatility rate of 138.43%, the RSI 9-day stood at 65.57% on 30 August.
With respect to its five-day moving average, the current P3 Health Partners Inc. price is up by +47.33% percent or $0.6650. At present, PIII shares trade -4.17% below its 20-day simple moving average and +102.94% percent above its 100-day simple moving average. However, the stock is currently trading approximately -52.95% below its SMA50 and -61.88% below its SMA200.
Stochastic coefficient K was 67.69% and Stochastic coefficient D was 43.09%, while ATR was 0.2084. Given the Stochastic reading of 85.47% for the 14-day period, the RSI (14) reading has been calculated as 54.60%. As of today, the MACD Oscillator reading stands at 0.2917, while the 14-day reading stands at 0.2638.
Analyst Ratings
TD Cowen launched its rating on P3 Health Partners Inc. (NASDAQ: PIII) to a Market perform in a note to investors on June 30, 2023. P3 Health Partners Inc. (PIII) has been rated Overweight by analysts. According to 0 brokerage firms, PIII is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate P3 Health Partners Inc. stock as buy, with 3 recommending it as overweight.
With a median target price of $4.00, the current consensus forecast for the stock is $3.50 – $9.00. Based on these forecasts, analysts predict P3 Health Partners Inc. (PIII) will achieve an average price target of $5.50.
